Cite

HARVARD Citation

    Mitchell, A. et al. (2022). Real-World Use of Bone-Modifying Agents in Metastatic Castration-Sensitive Prostate Cancer. Journal of the National Cancer Institute. pp. 419-426. [Online]. 
  
Back to record